A juicy new story highlights the drug diet of some of Silicon Valley’s most powerful individuals, including Elon Musk.
The story, published last week by the Wall Street Journal, claimed that Musk, the CEO of Tesla and owner of Twitter, takes ketamine and that Google co-founder Sergey Brin likes to dabble with psychedelic mushrooms.
“Routine drug use has moved from an after-hours activity squarely into corporate culture, leaving boards and business leaders to wrestle with their responsibilities for a workforce that frequently uses. At the vanguard are tech executives and employees who see psychedelics and similar substances, among them psilocybin, ketamine and LSD, as gateways to business breakthroughs,” the story said.
According to the Journal, the “account of Musk’s drug use comes from people who witnessed him use ketamine and others with direct knowledge of his use.”
After the story was published, Musk took to Twitter to tout ketamine’s virtues as a treatment for depression.
“Depression is overdiagnosed in the US, but for some people it really is a brain chemistry issue,” Musk tweeted on Tuesday. “But zombifying people with SSRIs for sure happens way too much. From what I’ve seen with friends, ketamine taken occasionally is a better option.”
Musk has spoken favorably about certain drugs in the past. Speaking at CodeCon in 2021, Musk said that people should be “open to psychedelics.”
“A lot of people making laws are kind of from a different era,” Musk said at the conference. “As the new generation gets into political power, I think we will see greater receptivity to the benefits of psychedelics.”
Musk also memorably shared a blunt with Joe Rogan on the latter’s popular podcast in 2018.
“I know a lot of people like weed and that’s fine,” Musk told Rogan during the interview, “but …
Read More
Author: Thomas Edward / High Times
